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Caffeic acid phenethyl ester (CAPE) is considered as 
one of the most active components of Propolis extract 
(PE), a natural product obtained from beehives. PE 
comprises a complex of chemicals and has been found 
to have various biological activities. The aim of the 
present study is to assess the antibacterial activities 
CAPE has against various gram positive [gram (+)] 
and gram negative [gram (-)]  bacteria and try to eluci-
date its mechanism of action. Bacteria were grown in 
the presence of various doses of CAPE and examined 
at different periods of time for their growth, both by 
absorbance (OD) measurement and colony assay. The 
results show that CAPE significantly inhibited the 
growth of most examined gram (+) bacteria while hav-
ing only a slight inhibitory effect on most tested gram 
(-) bacteria. Our results also show that continuous 
treatment of gram (+) bacteria with CAPE for at least 
6h caused irreversible inhibition of the bacterial 
growth (bacteriocidic effect); however, treatment for 
shorter periods of time caused only a stopping of bac-
terial growth (bacteriostatic effect). It seems that these 
effects were caused, at least partially, as a result of 
disruptions of the treated bacterial outer and plasma 
membranes. There is no significant synergistic effect 
between CAPE and ampicillin, although an additive 
effect has been found.  
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Antimicrobial activities of caffeic acid phenethyl ester 
Introduction 
 
The use of natural products as medicines for the treat-
ment of various diseases has had a long history. Tradi-
tional healers, throughout history, have acquired de-
tailed knowledge regarding the use of medicinal plants 
(Abel & Busia 2005). 
 It has been estimated that at least 25% of the 
active compounds present in currently prescribed syn-
thetic drugs were first identified in natural sources. In 
this regard, the investigation of natural products and 
their potential therapeutic properties is essential 
(Halberstein 2005). Increasing efforts are currently 
being devoted towards novel applications for natural 
products and their derivatives for treating human dis-
eases. 
 PE is obtained from beehives and based on 
resins produced by honeybees from certain trees and 
plants, bee's wax and their secretions (Onlen et al. 
2007). Scientific research has revealed various biologi-
cal activities of PE such as antibacterial (Huang et al. 
2006, Velazquez et al. 2007), antiviral (Drago et al. 
2007, Huleihel & Eshanu 2002, Orsolić & Basić 2005, 
Salomão et al. 2008, Viuda-Martos et al. 2008, Yao et 
al. 2004), antioxidant (Ahn et al. 2007, Kerem et al. 
2006), antifungal (Quiroga et al. 2006, Silici & Koc 
2006), antiinflamatory (Harris et al. 2006, Wu et al. 
2006), antitumor (Akao et al. 2003) and other activi-
ties (de Rezende et al. 2008, Kosalec et al. 2005, 
Viuda-Martos et al. 2008). During the last few years, 
PE has also been used in the food industry as an addi-
tive as well as in beverages and nutritional supple-
ments to enhance health and prevent diseases 
(Velazquez et al. 2007). In addition, previous studies 
have reported antibacterial activity of PE mainly 
against gram (+) but not gram (-) bacteria (Velazquez 
et al. 2007). 
 The chemical composition of PE is complex 
and has not been completely elucidated. Mainly, dif-
ferences in the composition of PE have been found to 
depend on its origin but also among topical samples, 
depending on the local flora at the site of collection 
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(Salomão et al. 2008). Nevertheless, it is known that 
the most important group of compounds - in terms of 
amount and biochemical activity - is the flavonoids, 
which are thought to play a significant role in its bio-
logical activities (Viuda-Martos et al. 2008). 
 The most active and studied component of PE 
is caffeic acid phenethyl ester (CAPE), which is 
known to be a potent inhibitor of activation of NF-kB 
(Natarajan et al. 1996). A major part of CAPE bioac-
tivities is thought to be related to NF-kB inhibition  
(Marquez et al. 2004, Song et al. 2002, Yang et al. 
2005). CAPE has also been reported to be a potent anti
-inflammatory and antioxidant agent and possess sev-
eral antiviral, antibacterial and antifungal properties 
(Alici et al. 2015, Ilhan et al. 1999, Tolba et al. 2013, 
Velazquez et al. 2007). 
 In this work, we tested the inhibitory effects of 
an aqueous extract of CAPE in vitro against different 
gram (+) and gram (-) bacteria, trying to elucidate its 
antibacterial mechanism of action. 
 
Materials and Methods 
 
CAPE 
CAPE was purchased as a powder from Sigma-Aldrich 
Corporation, USA. A stock solution of this product 
was prepared by dissolving it in dimethyl sulfoxide 
(DMSO) and then making the appropriate concentra-
tions for examining its activity by dilution with bacte-
rial growth medium (LB medium). 
 
Bacteria 
In the present study, the following gram (-) bacteria 
were used: Escherichia (E.) coli, Serratia (S.) 
marcescens, Pseudomonas (P.) aeruginosa, 
Haemophilus (H.) influenza, Pseudomonas, Shegella, 
Salmonella (S.) entenidis, Neisseria and Klebsiella. 
The gram (+) bacteria used were the following: 
Staphylococcus (Staph.) aureus, Micrococcus, Strepto-
coccus (S.) olysgalactiae, Streptococcus (S.) mitis, Ba-
cillus (B.) subtilis, B. cereus, B. megaterium and B. 
thuringiensis. 
 All the above bacterial strains were supplied 
by Dr Valentina Pavlov from the microbiology depart-
ment in our institute. All bacteria were grown on Nu-
trient Agar (Difco) at 37 °C. 
 
Measurement of bacterial amount 
The amounts of bacteria were evaluated by 2 different 
methods. Their optical density (OD) was examined by 
spectrophotometer at a wavelength of 620nm. This 
method gives an evaluation of the live and dead bacte-
ria. The other method involved counting bacterial 
colonies, by plating raising dilutions of each bacteria 
on LB agar plates for 24h at 37°C and counting the 
number of the obtained colonies. This method only 
gives the number of live bacteria. 
 
Antibacterial activity 
In order to examine the antibacterial activity of the 
tested products, we grew the appropriate bacteria over-
night and diluted them with LB medium to obtain 
about 104 colony-forming units (cfu)/mL, as estimated 
by optical density (OD630nm) and plating on agar ex-
aminations. These suspensions were used as inoculates 
in the antimicrobial activity tests. Various concentra-
tions of the tested material (CAPE) were added to the 
appropriate bacterial suspension with a final volume of 
10ml. Following this, treated and untreated bacterial 
suspensions were incubated at 37°C in a shaking incu-
bator. Thereafter, the following steps were undertaken 
at different time-points post-treatment: (a) the OD630nm 
of these samples was measured and corrected by sub-
traction of the OD630nm of PE or CAPE alone in sterile 
LB; (b) 0.5ml from each suspension was centrifuged at 
2000g for 15 minutes, washed twice with sterile dis-
tilled  water (ddH2O), resuspended in 0.2ml LB, plated 
on agar plates, incubated at 37°C for 24h and the num-
ber of colonies was counted. The lowest concentrate of 
CAPE that prevented bacterial growth was considered 
to be the minimum inhibitory concentration (MIC). 
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Bacterial species Gram ( +/-) MIC (mM) 
S. aureus + 48±2.5 
S. olysgalactiae + 48±3.1 
S. mitis + 55±2.8 
B. thuringiensi + 250±10.5 
(B.) subtilis + 70±3.2 
B. cereus + 96±2.8 
B. megaterium + 50±2.6 
Micrococcus + 55±2.6 
E. coli - 254±15.1 
S. marcescens - 400±23.7 
P. aeruginosa - 500±25.1 
H. influenza - 200±12.1 
Pseudomonas - 400±26.1 
S. entenidis - 60±2.70 
Neisseria - 500±24.3 
Klebsiella - 50±3.10 
Table 1.  Minimum inhibitory concentration (MIC) of 
CAPE on different species of gram (+) and gram (-) bacte-
ria. 
Combined antibacterial activity with ampicillin  
In the present study we examined possible synergistic 
or additive activity between CAPE and ampicillin, as a 
representative antibiotic against different gram (+) and 
gram (-) bacteria, according to Bonapace et al. (2002). 
Briefly, overnight working bacterial broth cultures 
were diluted in LB medium together with 10% serial 
dilutions of CAPE and different ampicillin combina-
tions, so as to give about 104 cfu/mL. Samples without 
treatment were used as controls. The cultures were in-
cubated for 24h at a 37oC incubator with shaking. 
MICs were determined for each tested bacterial strain 
and the interaction between CAPE and ampicillin was 
calculated by the fractional inhibitory concentration 
(FIC) index of the combination. The FIC for each anti-
bacterial agent was calculated as the ratio of the MIC 
of the agent in combination (with the other tested 
agent) to its MIC alone. In addition, the FIC index 
equals the FIC of CAPE plus the FIC of ampicillin. 
The interaction between the two agents was considered 
as synergy when the FIC index was ≤ 0.5, additivity/no 
interaction when the FIC index was between 0.5 to 4 
and antagonism when the FIC index >4.  
 
Gentian violet uptake by gram (+) and gram (-) 
bacteria 
CAPE treated bacteria (1 ml) were centrifuged at 2000 
rpm for 15 minutes at room temperature, washed twice 
with ddH2O, resuspended in 1 ml of ddH2O containing 
gentian violet (10µg/ml) and incubated for 10 min at 
37°C under vigorous shaking. The cells were removed 
by centrifugation and the amount of gentian violet re-
maining in the supernatant was measured at 590 nm in 
a spectrophotometer.  
 
Loss of 260nm absorbing material 
The release of UV-absorbing materials was measured 
by a UV–VIS spectrophotometer. Overnight cultures 
of gram (+) and gram (-) bacteria were adjusted to an 
OD600 of 1.0. Bacterial cells were centrifuged at 2000 
rpm for 15 minutes, the supernatant was discarded, and 
the resulting pellet was washed twice and then resus-
pended in 1 ml of PBS (pH 7.4). Different concentra-
tions of CAPE were added to the bacterial suspensions. 
All samples were incubated at 37oC for different peri-
ods of time (2 or 6h) and centrifuged at 13,000rpm for 
15 min, before the OD260 value of the supernatant 
was measured. 
 
Fourier-transform infrared (FTIR) microscopy 
The alteration in structural features of gram (+) and 
gram (-) bacteria at the molecular level upon treatment 
with PE or CAPE was analyzed by FTIR spectroscopy. 
Different doses of CAPE were added to the cell sus-
pensions of the examined bacteria, from overnight cul-
tures with an OD600 of 1.0. Treatment was performed 
for 6h at 37oC. The cells were then pelleted by cen-
trifugation at 3000 rpm for 5 min and washed three 
times with distilled water. The bacterial pellet was re-
suspended in 100µl of distilled water and 1µl of the 
obtained suspension was placed on a certain area on a 
zinc sellenide crystal, air dried for 15min at room tem-
perature (or for 5 min by air drying in a laminar flow) 
and examined by FTIR microscopy. 
 FTIR measurements were performed in the 
transmission mode with a liquid-nitrogen-cooled MCT 
detector of the FTIR microscope (Bruker IRScope II) 
coupled to an FTIR spectrometer (BRUKER EQUI-
NOX model 55/S, OPUS software). The spectra were 
obtained in the wave number range of 600‑4000 cm-1. 
Spectral resolution was set at 4 cm-1. Baseline correc-
tion by the rubber band method and vector normaliza-
tion was obtained for all the spectra by OPUS soft-
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Figure 1. Effect of CAPE on Gram (+) and Gram (-) bacte-
ria. Various concentrations of CAPE were added to 0.1 OD 
suspensions of S. aureus (A) and E. coli (B) and incubated 
at 37°C with shaking. In parallel, the appropriate suspen-
sions were treated with 100 µg/ml of ampicillin as a positive 
control. At different time-points post-treatment, the amount 
of the bacteria was determined by measuring their OD630nm. 
The results are means ± SD (n=5). 
ware. Peak positions were determined by means of a 




Effect of CAPE on Gram (+) and Gram (-) bacteria 
To determine the antibacterial activity of CAPE, we 
evaluated its effect on Gram (+) (S. aureus, Micrococ-
cus, S. olysgalactiae, S. mitis, B. subtilis, B. cereus, B. 
megaterium and B. thuringiensis) and Gram (-) (E. 
coli, S. marcescens, P. aeruginosa, H. influenza, Pseu-
domonas, Shegella, S. entenidis, Neisseria and Kleb-
siella) bacteria. 
 Various concentrations of the tested material 
(CAPE) were added to the appropriate bacterial sus-
pension (0.1 OD) and incubated at 37°C with shaking. 
At various time-points post-treatment the amount of 
the bacteria was determined by both measuring their 
OD630nm and counting growing colonies.  
 CAPE showed strong antibacterial activity 
against most of the gram (+) bacteria examined, in a 
concentration dependent manner (Table 1 and Figure 
1A, C), while it only had a slight and weak antibacte-
rial activity against most of the gram (-) bacteria exam-
ined (Table 1 and Figure 1B, D). However, CAPE 
showed weak antibacterial activity against the gram 
(+) bacteria B. Thuringiensi and a strong activity 
against the gram (-) bacteria S. Entenidis and Kleb-
siella (Table 1).  
 It can also be seen that continuous treatment 
with 50mM of CAPE caused a complete inhibition of 
all gram (+) bacterial growth up to the end of the ex-
periment (48h post-treatment), while continuous treat-
ment with lower doses (10mM of CAPE) caused a 
slower growth of gram (+) bacteria compared to the 
untreated control bacteria, as determined by measuring 
their OD630nm (Figure 1A, C). However, continuous 
treatment with even 500mM of CAPE only caused a 
reduction in the growth rate of all gram (-) bacteria 
examined, as can be seen in the representative results 
in Figure 1B and D. 
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Figure 2. Effect of CAPE on bacteria colony growth. Sus-
pensions (0.1 OD) of S. aureus (A) and E. coli (B) were 
treated with 50mM of CAPE and incubated at 37°C with 
shaking. At different time-points post-treatment, the amount 
of the living bacteria was determined by counting bacterial 
colonies. The results are means ± SD (n=5). 
Figure 3. Effect of CAPE treatment termination on bacterial 
growth. Suspensions (0.1 OD) of S. aureus were treated 
with 50 mM CAPE and at different time-points treatment 
was terminated by exchanging the bacterial culture medium 
with a fresh medium free of the examined products. These 
bacterial cultures were incubated at 37°C with shaking and 
their growth was examined at different time-points post-
treatment by measuring their absorbance (OD) (A) and by 
counting growing colonies (colony assay) (B). The results 
are means ± SD (n=5). 
 When the amount of living bacteria was deter-
mined by counting bacterial colonies, at different time-
points post-treatment with 50mM of CAPE, it was 
found that treatment for up to 4h caused a significant 
decrease in the number of the gram (+) bacteria colo-
nies, compared to the untreated control (Figure 2A). 
This result is mainly attributed to the increase in the 
number of the control bacteria, while the number of the 
treated bacteria did not change significantly over this 
period of time. In addition, the size of the treated bac-
terial colonies was significantly smaller than that of 
the controls. However, treatment for 6h or more caused 
complete death of all bacteria treated (Figure 2A). 
Treatment of the gram (-) bacteria with 500mM of 
CAPE reduced the number of bacterial colonies as a 
function of treatment time (Figure 2B). 
 
Effect of CAPE treatment termination on bacterial 
growth  
Trying to examine the antibacterial mechanism of 
CAPE, different gram (+) bacteria were treated with 50 
mM CAPE, and at different time-points the treatment 
was terminated by exchanging the bacterial culture 
medium with a fresh medium, free of the examined 
products. These bacterial cultures were incubated at 
37°C in a shaking incubator and their growth was ex-
amined at different time-points. The results obtained, 
either by OD measurement (Figure 3A and B) or colo-
nies counting (Figure 3C) showed that continuous 
treatment of the bacterial culture with PE or CAPE for 
up to 4h only caused a delay of about 5h in the growth 
of the bacteria, which was followed by a moderate 
growth compared to the untreated control cultures. 
However, continuous treatment for 6h caused complete 
death of the bacteria without any recovery, even 2 days 
after the termination of the treatment.  
 
Effect of CAPE treatment on bacterial outer mem-
brane (OM) permeability 
The effect of CAPE treatment on OM permeability of 
gram (+) and gram (-) bacteria to crystal violet was 
examined. It is known that gentian violet poorly pene-
trates the intact bacterial OM (Devi et al. 2010); there-
fore, it is possible to examine the effect of CAPE treat-
ment on OM permeability by examining the effect on 
gentian violet uptake by the treated bacteria. Different 
gram (+) and gram (-) bacteria were treated with vari-
ous doses of CAPE for 2 or 8h; the bacteria were the 
centrifuged, resuspended in 1 ml of ddH2O containing 
gentian violet (10µg/ml) and incubated for 10 min at 
37°C, under vigorous shaking as described in the 
“Materials and Methods” section. The gentian violet 
uptake was determined by measuring the remaining 
amount in the supernatant. The gentian violet uptake of 
the control untreated gram (+) and gram (-) bacteria 
was 4-10% of the input; however, it increased dramati-
cally in gram (+) bacteria in a dose dependent mater, 
reaching over 95% uptake at the higher doses after 8h 
of treatment with CAPE (Figure 4A). Also, in the case 
of gram (-) bacteria there was a gradual and significant 
increase in the gentian violet uptake at the higher doses 
of CAPE (Figure 4A), although this increase was pro-
foundly lower compared to the gram (+) bacteria. It 
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Figure 4. Effect of CAPE treatment on gentian violet uptake 
and on 260nm absorbing material loss by gram (+) and gram 
(-) bacteria. 1ml suspensions (0.5 OD) of S. aureus and E. 
coli were treated with different doses of CAPE for different 
periods of time (2 or 8h), then: (A) the bacteria were centri-
fuged at 2000 g for 15 minutes, bacterial pellets were 
washed twice with ddH2O, resuspended in 1ml of ddH2O 
containing gentian violet (10µg/ml) and incubated for 10 
min at 37°C under vigorous shaking. The bacteria were re-
moved by centrifugation and the amount of gentian violet 
remaining in the supernatant was measured at 590 nm in a 
spectrophotometer;  (B) the bacteria were pelleted as above 
and the OD260 value of the supernatant was measured. The 
results are means ± SD (n=5). 
should also be noted that a short treatment of 2h with 
CAPE caused a moderate increase in the gentian violet 
uptake in gram (+) and gram (-) bacteria. 
 
Effect of CAPE on release of 260nm absorbing ma-
terials from gram (+) and gram (-) bacteria 
Different gram (+) and gram (-) bacteria (1 OD) were 
treated with various amounts of CAPE for 2 or 8h. The 
bacteria were then centrifuged and the OD260 values 
of the supernatants were measured. It is known that 
measuring the release of UV-absorbing materials is an 
index of cell lysis (Zhou et al. 2008). Our results 
showed that an 8h treatment of gram (+) bacteria with 
CAPE caused a significant increase in the OD (from 
0.01 up to 0.3) while it resulted in a significantly lower 
increase in the case of gram (-) bacteria (from 0.01 up 
to 0.09) (Figure 4B). 
 
Effect of heat treatment or light exposure on CAPE 
antibacterial activity 
PE is rich with aromatic and flavonoid components 
which are, at least in part, sensitive to photo-oxidation 
that might affect their antibacterial activity. Two main 
theories have been put forward to explain the antibac-
terial capacity of honey and probably of PE (Viuda-
Martos et al. 2008). The first one assumes that it is due 
to the action of hydrogen peroxide that is produced by 
glucose oxidase in the presence of light and heat 
(Dustmann 1979), while the other one states that it is a 
nonperoxide activity that is independent of light and 
heat (Roth et al. 1986).  
 In this regard, we sought to examine the effect 
of high temperatures and light exposure on the antibac-
terial activity of CAPE. Different doses of CAPE were 
exposed to a high temperature or light for different 
periods of time and their antibacterial activity against 
gram (+) bacteria was examined. The results showed 
that neither incubation of CAPE in 100oC for 2 or 6h 
nor exposure to light for 24 or 48h had an effect on its 
antibacterial activity (Figure 5).  
 
Combined antibacterial activity with ampicillin 
We examined possible synergistic or additive activity 
between CAPE and ampicillin, as a representative anti-
biotic against different gram (+) and gram (-) bacteria. 
Our results, presented in Table 2, show that the FIC 
indices of CAPE plus ampicillin against all examined 
bacteria were above 0.5. Therefore, it seems that these 
combinations had only additive activity against the 
different tested bacteria without synergistic activity. 
 
Spectral changes in gram (+) and gram (-) bacteria 
treated with CAPE 
FTIR spectroscopy can be used to detect and monitor 
characteristic changes in molecular compositions and 
structures of living cells, providing a wealth of qualita-
tive and quantitative information about a given sample. 
The infrared spectrum of any compound is known to 
give a unique "finger print" (Naumann et al. 1991). In 
addition, the large information already known about 
spectral peaks obtained from FTIR spectra of living 
cells (Diem et al. 1999) make FTIR spectroscopy an 
attractive technique for detection and identification of 
pathogens. This technique has been previously used 
for the detection and characterization of cancer cells 
(Erukhimovitch et al. 2002), cells infected with viruses 




CAPE (μM) Amp (μg/ml)  CAPE + Amp CAPE Amp 
S. aureus 48 64 16 + 24 0.33 0.37 0.70 
B. cereus 96 64 30 + 32 0.31 0.50 0.81 
E. coli 254 48 96 + 30 0.38 0.62 1.00 
Neisseria 500 96 180 + 50 0.36 0.52 0.88 
Table 2. Minimum inhibitory concentration (MIC), fractional inhibitory concentration (FIC) and FIC index of CAPE and am-
picillin against different gram (+) and gram (-) bacteria. 
Figure 5. Effect of heat and light on CAPE antibacterial 
activities. Different doses of CAPE  were incubated at 
100C˚ or continuously exposed to a 100w lamp light for 
different periods of time.  They were then added to 0.1 OD 
suspensions of S. aureus, incubated at 37°C with shaking 
and bacterial growth was examined at different time-points 
post-treatment by measuring their absorbance (OD). The 
results are means ± SD (n=5). 
(Salman et al. 2002) and microorganisms 
(Erukhimovitch et al. 2002, Maquelin et al. 2003, 
Mariey et al. 2001).  
 In the present study, gram (+) and gram (-) 
bacteria were treated with different doses of PE for 6h 
and examined by FTIR spectroscopy. Significant spec-
tral changes were observed in the frequency between 
1700 and 1000cm−1 in CAPE treated samples of S. 
aureus (Figure 6A) compared to the slight spectral 
changes in the treated E. coli (Figure 6B), which may 
indicate an apparent deformation in the treated cells. 
These spectral changes were associated with changes 
in different components of the treated bacteria, such as 
proteins, polysaccharides, nucleic acids and lipids. 
There is a significant increase in frequency at 1100 and 
1250 cm−1 of the CAPE-treated bacteria, which may 
indicate an alteration in polysaccharide and phosphate 
components. These differences may reflect changes in 
the content or distribution of the above components 





In the present study we examined the antibacterial ac-
tivity of CAPE (one of the active components of PE) 
against various gram (+) and gram (-) bacteria. CAPE 
showed potent and impressive antibacterial activity 
against most tested gram (+) bacteria, while it only had 
moderate and partial activity against gram (-) bacteria. 
This observation is in complete agreement with previ-
ous studies which have shown that gram (+) bacteria 
are more susceptible to the antibacterial effect of PE or 
CAPE than gram (-) bacteria (Drago et al. 2007, Ve-
lazquez et al. 2007). In fact, various kinds of PE have 
been found to have multiple biological effects such as 
antiviral (Drago et al. 2007, Huleihel & Eshanu 2002, 
Orsolic & Basic 2005, Salomão et al. 2008, Viuda-
Martos et al. 2008, Yao et al. 2004), antioxidant (Ahn 
et al. 2007, Kerem et al. 2006), antifungal (Quiroga et 
al. 2006, Silici & Koc 2006) and antibacterial (Huang 
et al. 2006, Velazquez et al. 2007) activities, mainly 
due to the presence of phenolic compounds and fla-
vonoids (Viuda-Martos et al. 2008). Flavonoids, cin-
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Figure 6.  FTIR spectroscopy of gram (+) and gram (-) bacteria treated with CAPE.  S. aureus and E. coli were treated with 
different doses of CAPE for 6h and examined by FTIR spectroscopy. 
namic acids and their ester derivatives have been found 
to be the most abundant and effective antimicrobial 
compounds in PE (Diem et al. 1999, Dustmann 1979, 
Erukhimovitch et al. 2002, Fontana et al. 2004, Fuji-
wara et al. 1990, Isla et al. 2001, Maquelin et al. 2003, 
Mariey et al. 2001, Martos et al. 1997, Naumann et al. 
1991, Pascual et al. 1994, Roth et al. 1986, Salman et 
al. 2002). 
 Although our results didn't show any synergis-
tic effect between CAPE and ampicillin, a significant 
additive effect between these agents can been seen 
(Table 2). These results may indicate that the mecha-
nisms of action of CAPE and ampicillin are not re-
lated. 
 The exact mechanism of anti-bacterial activity 
of CAPE is still unclear. Our results showed that con-
tinuous treatment with CAPE for up to 6h caused a 
reversible antibacterial effect; however continuous 
treatment for longer periods of time caused irreversible 
inhibition of the bacterial growth (Figure 3). Also, the 
data presented in Figure 2 showed that 4h of treatment 
with CAPE did not affect the viability of the treated 
bacteria, while treatment for 6h or more caused com-
plete bacterial death. It seems that this product has bac-
teriostatic effect during the first 5-6 h of treatment, 
while further treatment is required for a bacteriocidic 
effect. 
 Burdock (1998) attributes the antibacterial ac-
tivity of PE to the aromatic acids and esters, while an-
other study (Takaisi & Schilcher 1994) suggested it is 
due to flavonone pinocembrin, the flavonol galangin 
and CAPE, whose mechanism of action seems to rely 
on the inhibition of the bacterial RNA polymerase. 
Others have shown that other flavonoids, including 
galangin, can also have antibacterial activity (Cushnie 
& Lamb 2005). The mechanism of action involves de-
grading the bacterial cytoplasmic membrane, which 
causes a loss of potassium ions and further damage, 
leading to cell autolysis. Furthermore, quercetin, which 
is also found in PE, has been reported to increase 
membrane permeability and dissipate its potential, 
causing loss of the ATP synthesis capacity by the bac-
teria as well as dysfunction of membrane transport and 
mobility (Mirzoeva et al. 1997). 
 The effect of CAPE on the permeability of the 
bacterial outer membrane was assessed by the uptake 
of the crystal violet dye. Generally, crystal violet pene-
trates the outer membrane poorly, but it easily enters 
when the membrane is defective (Devi et al. 2010).  
Our results showed a dramatic enhancement in the up-
take of crystal violet in gram (+) bacteria in a dose de-
pendent mater, reaching over 95% uptake at the higher 
doses after 8h of treatment with CAPE (Figure 4A). In 
the case of gram (-) bacteria, there also was a signifi-
cant increase in gentian violet uptake at the higher 
doses of CAPE (Figure 4A), even though this increase 
was much lower compared to gram (+) bacteria. After 
a 2h short treatment with CAPE, only a slight increase 
in the gentian violet uptake in gram (+) and gram (-) 
bacteria was observed. This shows that CAPE alters 
membrane permeability and makes the cells hyperper-
meable to solutes. These results are in agreement with 
our results showing significantly higher antibacterial 
activity of this product against gram (+), as compared 
to gram (-) bacteria. Taken together, these results to-
gether with our findings that CAPE treatment for over 
6h caused a bacteriocidic effect may indicate a dra-
matic irreversible disruption of the bacterial outer 
membrane, leading to bacterial death. 
 The escape of UV-absorbing substances from 
the cells is an index of membrane cell disruption and 
probably cell lysis and nonselective pore formation 
(Maisnier-Patin et al. 1996, Zhou et al. 2008). As seen 
in Figure 4B, treatment of S. aureus (a gram (+) strain) 
with CAPE caused a high leakage of intracellular com-
ponents compared to a lower leakage from the treated 
gram (-) bacteria. These results suggest that the effect 
of CAPE on gram (+) and partially on gram (-) bacte-
ria could be the formation of pores, or even a more 
severe disruption of the plasma membrane. 
 In addition, Scazzocchio et al. (2006) has re-
ported that PE suppresses the expression of different 
bacterial virulence factors such as lipase and coagu-
lase, while producing an evident suffering state of bac-
terial cells. 
 In this study, CAPE effectively inhibited the 
growth of most of the examined gram (+) bacteria, 
while they only had a limited effect on part of the gram 
(+) and on all tested gram (-) bacteria. This selective 
effect may be due to the presence of a capsule around 
these bacteria, which can prevent the penetration of the 
tested products into the bacteria. Therefore, at very 
high doses of the products, only small amounts of 
these products can penetrate into the capsular bacteria 
and partially affect their growth. 
 FTIR spectroscopy is a potential method used 
to study spectral changes in living cells 
(Erukhimovitch et al. 2002, Fontana et al. 2004, Fuji-
wara et al. 1990). Infrared spectra of microbial cells 
reflect the biochemical structure and composition of 
the cellular constituents such as water, fatty acids, pro-
teins, polysaccharides and nucleic acids. In our study, 
major spectral variations were observed in the frequen-
cies between 1800 and 1000cm−1. More specifically, 
our results showed a significant increase in frequency 
at 1100cm−1 of the CAPE-treated bacteria. This may 
indicate an alteration in the polysaccharide content or 
distribution, probably of the bacterial envelope. This 
28   Journal of Molecular Biochemistry, 2015 
result supports our findings showing a disruption of 
the bacterial outer membrane as a result of treatment 
with CAPE (Figure 4A). In addition, there was another 
notable increase in the frequency at 1250cm−1 of the 
CAPE-treated bacteria. This peak, which represents 
phosphate vibrations (Diem et al. 1999) may reflect 
significant changes in the phosphates. This could result 
from deformation in membrane phospholipids, sug-
gesting that CAPE alters the macromolecular struc-
tures in the membrane, which further results in the 
complete loss of its integrity. These findings are in 
agreement with our results pointing towards formation 
of pores or even more severe disruption of the plasma 
membrane in CAPE-treated bacteria (Figure 4B).  
 Although the obtained results in this study pro-
vided a significant contribution for understanding the 
antibacterial mechanism of CAPE action, still further 
research is required for elucidating its exact mecha-
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